Document Detail


Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
MedLine Citation:
PMID:  16023986     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Mutations in Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) genes have been used as means to predict treatment failure to sulfadoxine-pyrimethamine (SP) and for monitoring/surveillance of resistance to the drug in many areas where malaria is endemic. However, patients responses to treatment are significantly dependent on factors like host immunity profile of treated patients. In order to investigate the relationship between molecular markers of SP resistance, host immunity and clinical outcome, the association between pre-treatment dhfr and dhps genotypes, age and treatment outcomes was evaluated in 109 children treated with SP for acute uncomplicated malaria in Ibadan, Nigeria. Seventy-three percent of the children were cured with the drug, while 27% failed treatment after 28 days of follow-up. All children infected with parasites harboring less than two dhfr/dhps mutations were cured with SP. The dhfr triple (Asn-108/Ile-51/Arg-59) mutants or the dhps double mutants (Gly-437/Glu-540) were independently associated with SP treatment failure in children aged less than 5 years, but not in older children. The dhfr and dhps quintuple mutant (dhfr triple mutant+dhps double mutant) was the genotype most strongly associated with SP treatment failure (OR=24.72, 95%CI=8.24-74.15) in both younger and older children.
Authors:
C T Happi; G O Gbotosho; O A Folarin; D O Akinboye; B O Yusuf; O O Ebong; A Sowunmi; D E Kyle; W Milhous; D F Wirth; A M J Oduola
Related Documents :
20573266 - Prescribing practice for malaria following introduction of artemether-lumefantrine in a...
3050516 - Blood glucose levels in malawian children before and during the administration of intra...
12474476 - Risk of malaria attacks in gambian children is greater away from malaria vector breedin...
18999956 - Perfusion abnormalities in children with cerebral malaria and malarial retinopathy.
16870686 - Is undernutrition a problem among turkish school children?: which factors have an influ...
15214256 - Lysine fortification of wheat flour improves selected indices of the nutritional status...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Acta tropica     Volume:  95     ISSN:  0001-706X     ISO Abbreviation:  Acta Trop.     Publication Date:  2005 Sep 
Date Detail:
Created Date:  2005-08-29     Completed Date:  2005-10-12     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370374     Medline TA:  Acta Trop     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  183-93     Citation Subset:  IM    
Affiliation:
Malaria Research Laboratories, Postgraduate Institute for Medical Research and Training (PIMRAT), College of Medicine, University of Ibadan, Ibadan, Nigeria. christianhappi@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antimalarials / pharmacology,  therapeutic use*
Child
Child, Preschool
Dihydropteroate Synthase / genetics*
Drug Combinations
Drug Resistance / genetics*
Female
Humans
Infant
Malaria, Falciparum / drug therapy*,  immunology
Male
Nigeria
Plasmodium falciparum / drug effects,  genetics*,  isolation & purification
Polymorphism, Genetic
Pyrimethamine / pharmacology,  therapeutic use*
Sulfadoxine / pharmacology,  therapeutic use*
Tetrahydrofolate Dehydrogenase / genetics*
Treatment Outcome
Grant Support
ID/Acronym/Agency:
R03TW006298-01A1/TW/FIC NIH HHS
Chemical
Reg. No./Substance:
0/Antimalarials; 0/Drug Combinations; 2447-57-6/Sulfadoxine; 37338-39-9/sulfadoxine-pyrimethamine; 58-14-0/Pyrimethamine; EC 1.5.1.-/dihydrofolate reductase type II; EC 1.5.1.3/Tetrahydrofolate Dehydrogenase; EC 2.5.1.15/Dihydropteroate Synthase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genetic diversity of the msp-1 locus and symptomatic malaria in south-west Nigeria.
Next Document:  Ethical perspective on malaria research for Africa.